{
    "clinical_study": {
        "@rank": "77051", 
        "arm_group": [
            {
                "arm_group_label": "Cohort 1", 
                "arm_group_type": "Experimental", 
                "description": "Subjects will be randomized to receive injections JVS-100 or placebo."
            }, 
            {
                "arm_group_label": "Cohort 2", 
                "arm_group_type": "Experimental", 
                "description": "Subjects will be randomized to receive injections JVS-100 or placebo."
            }, 
            {
                "arm_group_label": "Cohort 3", 
                "arm_group_type": "Experimental", 
                "description": "Subjects will be randomized to receive injections of JVS-100 or placebo."
            }
        ], 
        "brief_summary": {
            "textblock": "This study will investigate the safety and efficacy of using JVS-100 to accelerate wound\n      healing and reduce scar formation in subjects receiving surgical incisions (\"sternotomies\")\n      during cardiovascular surgery. Twenty-five (25) subjects receiving a median sternotomy of 16\n      - 25 cm in the process of cardiothoracic surgery will be enrolled consecutively and be\n      followed for 6 months post-dosing. Three cohorts of approximately 8 subjects each will be\n      enrolled, and within each cohort subjects will be randomized 3:1 to receive a single set of\n      needle-free dermal injections of either JVS-100 or placebo. JVS-100 or placebo will be\n      delivered along the edge of the sternal wound using a needle-free injection device that has\n      FDA-clearance for subcutaneous injections."
        }, 
        "brief_title": "Study to Evaluate the Safety and Efficacy of Dermal Injections of JVS-100 Given to Adults Receiving Median Sternotomy", 
        "completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Median Sternotomy", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Men and women 40 - 80 years of age inclusive\n\n          -  Patients undergoing median sternotomy for cardiac surgical procedures, with incision\n             length of 16-25 cm\n\n          -  Subject must be able to understand the study procedures, agree to participate in the\n             study program, and voluntarily provide written informed consent\n\n          -  Subjects with BMI 25 - 40 kg/m2\n\n          -  All subjects age 50 or older must have had a Fecal occult blood test (FOBT) or fecal\n             immunochemical test (FIT) that was negative within the last year or a colonoscopy\n             within the last 10 years\n\n          -  Women age 40 - 65 must have had a Papanicolaou (PAP) test that was negative within\n             the last 5 years unless a total hysterectomy has been previously performed for benign\n             disease\n\n          -  Women age 40 or older must have had a mammogram that was negative within the last\n             year\n\n          -  All diabetic subjects must have had an ophthalmologic exam within the last year\n             showing no active proliferative retinopathy.\n\n        Exclusion Criteria:\n\n          -  Subject is scheduled for mechanical device assistance or, heart transplantation\n\n          -  Class IV heart failure\n\n          -  Subject had acute myocardial infarction less than 3 days prior to scheduled surgery\n\n          -  Subject is undergoing urgent bypass surgical procedure\n\n          -  History of scleroderma, a connective tissue disorder, rheumatoid arthritis, or\n             ankylosing spondylitis or systemic lupus erythematosus (SLE)\n\n          -  Pregnant or lactating women or subjects of childbearing potential not protected by an\n             effective method of birth control\n\n          -  Life expectancy of < 1 year\n\n          -  Diabetes mellitus with HgbA1C >10.5% tested within 2 weeks prior to surgery\n\n          -  Existing scarring in the area of study\n\n          -  Subject has received a cytotoxic agent or has a history of chest radiation therapy\n             and/or will likely require such treatment in the 30 day period following surgery, not\n             including use of radiation for diagnostic imaging, e.g., PET Scan, CT SCAN, Fluro,\n             Myocardial Perfusion (SPECT).\n\n          -  Chest tattoos over the sternum, breast implants, prior mastectomies or lumpectomies\n\n          -  Subject plans to use an alternative/accessory wound healing treatment\n\n          -  Infection being treated with systemic antibiotics within 3 days of scheduled surgery\n\n          -  Chronic kidney disease (stage 5) requiring dialysis\n\n          -  Significant Hepatic disease\n\n          -  Significant is known to be infected with HBV, HIV or HCV\n\n          -  Clinically significant elevations or decreases in PT/PTT/INR/WBC\n\n          -  Concurrent medical condition that is associated with prolonged recovery from surgery\n             (e.g.,  significant respiratory disease, high risk for ventilator dependence, current\n             use of systemic steroids)\n\n          -  Subject has cognitive impairment\n\n          -  Any patient with a history of cancer with the exception of: 1) The cancer was limited\n             to curable non-melanoma skin malignancies; 2) The cancer was removed by a successful\n             tumor resection, with or without radiation or chemotherapy treatment, 5 years or more\n             prior to enrollment in this study without recurrence.\n\n          -  Men unwilling to agree to barrier contraception unless previously received a\n             vasectomy\n\n          -  Presence of any other condition that, in the opinion of the investigator, might\n             compromise any aspect of the trial\n\n          -  Previous treatment with an angiogenic growth factor or with stem cell therapy within\n             1 year\n\n          -  Participation in another clinical trial of an investigational agent in the previous\n             30 days\n\n          -  History of drug or alcohol abuse in the past year"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "40 Years"
        }, 
        "enrollment": {
            "#text": "25", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 1, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01657045", 
            "org_study_id": "SRX-001"
        }, 
        "intervention": [
            {
                "arm_group_label": "Cohort 1", 
                "description": "Injections will be delivered depending on sternal incision length.", 
                "intervention_name": "JVS-100 or placebo", 
                "intervention_type": "Biological"
            }, 
            {
                "arm_group_label": "Cohort 2", 
                "description": "Injections will be delivered depending on sternal incision length.", 
                "intervention_name": "JVS-100 or placebo", 
                "intervention_type": "Biological"
            }, 
            {
                "arm_group_label": "Cohort 3", 
                "description": "Injections will be delivered depending on sternal incision length.", 
                "intervention_name": "JVS-100 or placebo", 
                "intervention_type": "Biological"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "Cicatrix", 
            "Wound healing"
        ], 
        "lastchanged_date": "July 22, 2013", 
        "location": [
            {
                "contact": {
                    "email": "yvonne.gopsill@ahss.org", 
                    "last_name": "Yvonne Gopsill, RN", 
                    "phone": "813-615-7527"
                }, 
                "facility": {
                    "address": {
                        "city": "Tampa", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33613"
                    }, 
                    "name": "Pepin Heart Institute"
                }, 
                "investigator": {
                    "last_name": "Marc Bloom, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "jirving@nmh.org", 
                    "last_name": "Jade Irving", 
                    "phone": "312-695-6854"
                }, 
                "facility": {
                    "address": {
                        "city": "Chicago", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "60611"
                    }, 
                    "name": "Northwestern University Bluhm Cardiovascular Inst"
                }, 
                "investigator": {
                    "last_name": "Patrick McCarthy, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "nsookraj@montefiore.org", 
                    "last_name": "Nadia Sookraj, RN", 
                    "phone": "718-920-6636"
                }, 
                "facility": {
                    "address": {
                        "city": "New York City", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10467"
                    }, 
                    "name": "Montefiore Medical Center"
                }, 
                "investigator": {
                    "last_name": "Robert Michler, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "rothr@summahealth.org", 
                    "last_name": "Robin Roth, RN", 
                    "phone": "330-375-3931"
                }, 
                "facility": {
                    "address": {
                        "city": "Akron", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "44304"
                    }, 
                    "name": "Summa Health System Hospital"
                }, 
                "investigator": {
                    "last_name": "Eric Espinal, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "patty.meldrum@hsc.utah.edu", 
                    "last_name": "Patty Meldrum, RN", 
                    "phone": "801-581-4121"
                }, 
                "facility": {
                    "address": {
                        "city": "Salt Lake City", 
                        "country": "United States", 
                        "state": "Utah", 
                        "zip": "84132"
                    }, 
                    "name": "University of Utah Hospital"
                }, 
                "investigator": {
                    "last_name": "Amit Patel, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "MMBULLIV@sentara.com", 
                    "last_name": "Melinda Bullivant, RN", 
                    "phone": "757-388-4024"
                }, 
                "facility": {
                    "address": {
                        "city": "Norfolk", 
                        "country": "United States", 
                        "state": "Virginia", 
                        "zip": "23507"
                    }, 
                    "name": "Sentara Cardiovascular Research Institute"
                }, 
                "investigator": {
                    "last_name": "Michael McGrath, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "3", 
        "official_title": "A Phase I Randomized, Double-Blind, Placebo Controlled Dose Escalation Study to Evaluate the Safety and Efficacy of JVS-100 Administered by Needle-free Dermal Injection to Cohorts of Adults Receiving Surgical Sternotomy Incisions", 
        "overall_contact": {
            "email": "tmiller@sironrx.com", 
            "last_name": "Timothy J Miller, Ph.D", 
            "phone": "216-445-5588"
        }, 
        "overall_official": [
            {
                "affiliation": "University of Utah", 
                "last_name": "Amit Patel, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Montefiore Medical Center", 
                "last_name": "Robert Michler, MD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "To investigate the safety and tolerability of ascending doses of JVS-100 delivered via needle-free dermal injections to subjects receiving surgical incisions following cardiothoracic surgery.", 
            "safety_issue": "Yes", 
            "time_frame": "6 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01657045"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "To investigate the preliminary efficacy of ascending doses JVS-100 delivered via needle-free dermal injections to subjects receiving surgical incisions following cardiothoracic surgery.", 
            "safety_issue": "No", 
            "time_frame": "6 months"
        }, 
        "source": "SironRX Therapeutics, Inc.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "SironRX Therapeutics, Inc.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "July 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "July 2013"
    }
}